To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Chronic myelogenous leukemia (CML); acute myelogenous leukemia (AML)
Cell culture and mouse studies suggest inhibiting protein PML
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury